Cressman, S., Karsan, A., Hogge, D., McPherson, E., Bolbocean, C., Regier, D., & Peacock, S. (2016). Economic impact of genomic diagnostics for intermediate‐risk acute myeloid leukaemia. Wiley.
Čikaški stil citiranja (17. izdanje)Cressman, S., A. Karsan, DE Hogge, E. McPherson, C. Bolbocean, DA Regier, i SJ Peacock. Economic Impact of Genomic Diagnostics for Intermediate‐risk Acute Myeloid Leukaemia. Wiley, 2016.
MLA način citiranja (9. izdanje)Cressman, S., et al. Economic Impact of Genomic Diagnostics for Intermediate‐risk Acute Myeloid Leukaemia. Wiley, 2016.
Upozorenje: Ovi citati možda nisu uvijek 100% točni.